期刊文献+

全球草药产品的质量和安全问题:监管和价值链对质量的影响 被引量:1

Quality and safety of herbal medical products:regulation and the need for quality assurance along the value chains
下载PDF
导出
摘要 草药和及其衍生的产品是不同的产品组,这类产品一般在其组成上不同,且通常处于一个难以理解的价值链末端,这将生物多样性丰富国家的生产者与北方的大市场联系起来。讨论当前草药医疗产品的监管框架,使用姜黄(Curcumal longaL.)代谢组学研究例子说明价值链如何影响这类产品的组成和质量(安全性)。
作者 本刊编译
出处 《亚太传统医药》 2016年第21期6-8,共3页 Asia-Pacific Traditional Medicine
  • 相关文献

参考文献14

  • 1IPSOS MORI. Public Perceptions of Herbal Medicines. Gen-- eral Public Qualitative & Quantitative Research. Ipsos Mori MHRA: London, UK. 2008.
  • 2DE SMET PAGM. Clinical risk management of herb-drug Interactions[J]. Br J Clin Pharrnacol, 2006,63 (3) :258-267.
  • 3EDWARDS S, DACOSTAROCHA I, LAWRENCE MJ, et al. A reappraisal of herbal medicinal products [J]. Nuts Times,2014,108(39) :24-27.
  • 4MICHL J, INGROUILLE M, SIMMONDS M, et al. Natu- rally occurring aristolochic acid analogues and their toxicities [J]. Nat Prod Reports 2014; 31: 676-693.
  • 5WHITTEN DL, MYERS SP, HAWRELAK JA, et al. The effect of St John's wort extracts on CYP3A: a systematic re- view of prospective clinical trials[J]. Br J Clin Pharmacol, 2006,62:512-526.
  • 6EDWARDS S, ROCHA I, WILLIAMSON EM, et al. Phy- topharmacy an evidence based guide to herbal medicines[M]. Wiley: Chichester,2015.
  • 7LOCKWOOD GB. The quality of commercially available nu- traceutical supplements and food sources[J]. J Pharm Phar- macol,2011,63(63) : 3-10.
  • 8HEINRICH M, BARNES J, GIBBONS S. et al. Fundamen- tals of Pharmacognosy and Phytotherapy. 2nd edition[M]. Edinburgh & London: Churchill Livingstone (Elsevier), 2012.
  • 9BILIA AR. Science meets regulation[J]. J Ethnopharmacol, 2014,158: 487-494.
  • 10DAMIANO F, SILVA C, GREGORI A, et al. Analysis of illicit dietary supplements sold in the Italian market[J]. SciJustice,2014,54(3) : 228-237.

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部